FIELD: medicine.
SUBSTANCE: pre-therapeutic patient's blood serum is examined for the content of cortisol and dehydroepiandrosterone sulphate (DHEAS). If the DHEAS concentration is more than 7000 nmol/l and the relation of DHEAS/cortisol is more than 11.0, the high clinical efficacy of the therapy is predicted.
EFFECT: predicted pre-therapeutic efficacy of the ladasten therapy of organic asthenic disorders, and enabled targeted rehabilitation pharmacological actions.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN DEPRESSIVE EPISODE | 2013 |
|
RU2530635C1 |
| METHOD OF PROGNOSIS OF CLINIC COURSE OF NEUROTIC DISORDERS | 2007 |
|
RU2356059C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING RESIDUAL SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTICS | 2006 |
|
RU2319155C2 |
| METHOD FOR PREDICTION OF COMORBID ANXIOUS DISORDER IN PATIENTS WITH RECURRENT DEPRESSIVE DISORDER | 2017 |
|
RU2644636C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF BORDER PSYCHIC DISORDERS | 2011 |
|
RU2455646C1 |
| METHOD OF ASSESSMENT OF ADAPTATION RESERVES OF HUMAN BODY | 2018 |
|
RU2679906C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
| METHOD FOR PREDICTING THERAPY EFFICIENCY FOR PATIENTS WITH ADJUSTMENT DISORDERS WITH ANXIETY-DEPRESSIVE SYMPTOMATIC | 2018 |
|
RU2677867C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF ADJUSTMENT DISORDER AND ORGANIC EMOTIONALLY LABILE DISORDER | 2022 |
|
RU2787638C1 |
| METHOD FOR PREDICTION OF RISK OF FORMATION OF ORGANIC ANXIETY DISORDER | 2019 |
|
RU2712915C1 |
